Advanced search
Publication Cover
Renal Failure Volume 39, 2017 - Issue 1
Submit an article Journal homepage
1,423
Views
3
CrossRef citations to date
0
Altmetric
Cilincal Study

Serum ferritin as an activity marker for granulamotosis with polyangiitis

Hamit KucukDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, TurkeyCorrespondence[email protected]
,
Ozkan VaranDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey
,
Berna GokerDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey
,
Berivan BitikDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey
,
Mehmet Akif OzturkDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey
,
Seminur HaznedarogluDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey
&
Abdurrahman TufanDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey
 show all
Pages 566-569 | Received 12 Dec 2016, Accepted 25 Jun 2017, Published online: 25 Jul 2017

References

  • Langford CA. Antineutrophil cytoplasmic antibodies should not be used to guide treatment in Wegener's granulomatosis. Clin Exp Rheumatol. 2004;22(6 Suppl 36):S3–S6.
  • Sebastian JK, Mahr AD, Ahmed SS, et al. Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations. J Rheumatol. 2007;34(5):1027–1031.
  • Kronbichler A, Kerschbaum J, Grundlinger G, et al. Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis. Nephrol Dial Transplant. 2016;31(6):930–936.
  • Monach PA, Tomasson G, Specks U, et al. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2011;63(12):3988–3997.
  • Recalcati S, Invernizzi P, Arosio P, Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008;30(1–2):84–89.
  • Surguladze N, Thompson KM, Beard JL, et al. Interactions and reactions of ferritin with DNA. J Biol Chem. 2004;279(15):14694–14702.
  • Knovich MA, Storey JA, Coffman LG, et al. Ferritin for the clinician. Blood Rev. 2009;23(3):95–104.
  • Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99(10):3505–3516.
  • Ruscitti P, Cipriani P, Di Benedetto P, et al. Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. Autoimmun Rev. 2015;14(5):429–437.
  • Garcia PC, Longhi F, Branco RG, et al. Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr. 2007;96(12):1829–1831.
  • Doring M, Stanchi KMC, Feucht J, et al. Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients. Ann Hematol. 2016;95(2):311–323.
  • Beyan E, Beyan C, Demirezer A, et al. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus. Scand J Rheumatol. 2003;32(4):225–228.
  • Ishizuka M, Watanabe R, Ishii T, et al. Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors. Mod Rheumatol. 2016;26(1):115–120.
  • Tripathy R, Panda AK, Das BK. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE. Lupus. 2015;24(1):82–89.
  • Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–192.
  • Stone JH, Hoffman GS, Merkel PA, et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum. 2001;44(4):912–920.
  • Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–772.
  • Brijker F, Magee CC, Tervaert JW, et al. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol. 1999;52(6):344–351.
  • Flossmann O. Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis. Presse Med. 2015;44(6 Pt 2):e251–e257.
  • Luqmani RA. State of the art in the treatment of systemic vasculitides. Front Immunol. 2014;5:471.
  • Kallenberg CG. Pathogenesis and treatment of ANCA-associated vasculitides. Clin Exp Rheumatol. 2015;33(4 Suppl 92):S11–S14.
  • Kawasumi H, Gono T, Kawaguchi Y, et al. IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositis. Biomed Res Int. 2014;2014:815245.
  • Mehta B, Efthimiou P. Ferritin in adult-onset still's disease: just a useful innocent bystander? Int J Inflam. 2012;2012:298405.
  • Rosario C, Zandman-Goddard G, Meyron-Holtz EG, et al. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.